Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

F Hoffmann la Roche Ag
F Hoffmann la Roche Ag roche Glycart Ag
  

F Hoffmann la Roche Ag patents

Recent patent applications related to F Hoffmann la Roche Ag. F Hoffmann la Roche Ag is listed as an Agent/Assignee. Note: F Hoffmann la Roche Ag may have other listings under different names/spellings. We're not affiliated with F Hoffmann la Roche Ag, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "F" | F Hoffmann la Roche Ag-related inventors




Date F Hoffmann la Roche Ag patents (updated weekly) - BOOKMARK this page
07/20/17 new patent  Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
06/22/17Blood-brain barrier shuttles containing antibodies recognizing alpha-synuclein
05/11/17Compounds for treating spinal muscular atrophy
04/13/17Pyrrolopyrazine derivatives for use in the treatment, amelioration or prevention of influenza
03/23/17Triazolones derivatives for use in the treatment, amelioration or prevention of a viral disease
03/23/17Triazolones derivatives and their use in the treatment, amelioration or prevention of a viral disease
03/23/17Pyrazolopyrazines and their use in the treatment, amelioration or prevention of a viral disease
03/16/17Gpc3-targeting drug which is administered to patient responsive to gpc3-targeting drug therapy
03/02/17Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof
01/05/17Cap/endo dual inhibitors and their use in the treatment, amelioration or prevention of a viral disease
12/22/16Heterocyclic pyrimidine carbonic acid derivatives which are useful in the treatment, amelioration or prevention of a viral disease
12/15/167-oxo-thiazolopyridine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
12/08/16Oligopeptide and methods for producing conjugates thereof
12/01/16Camelid single-domain antibody directed against amyloid beta and methods for producing conjugates thereof
11/17/16Purification of erythropoietin
10/13/16Processes for the preparation of pyrimidinylcyclopentane compounds
10/06/16Training device for medicine injection devices and reset device for resetting such a training device
06/23/16Method for treating joint damage
06/09/16Device for use in the detection of binding affinities
05/26/16Compounds for treating spinal muscular atrophy
02/11/16Naphthyridinone derivatives and their use in the treatment, amelioration or prevention of a viral disease
01/14/16Method and system for determining a biological response of a target to a soluble candidate substance
01/07/16Pyridopyrazine compounds and their use in the treatment, amelioration or prevention of influenza
01/07/16Cap/endo dual inhibitors and their use in the treatment, amelioration or prevention of a viral disease
12/24/15Lna oligonucleotide carbohydrate conjugates
10/22/15Substituted triazole and imidazole compounds
10/22/15Compositions and methods for inhibiting hypoxia induced damage
10/15/15Mimetic peptides
08/27/15System for dispensing a sample into a buffer liquid
06/18/15Compounds for treating spinal muscular atrophy
05/21/15Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
04/30/15Compounds for treating spinal muscular atrophy
01/29/15Fluoromethyl-5,6-dihydro-4h-[1,3]oxazines
01/15/15Sample handling system
01/01/15Method for training staff in quality control
01/01/15Compounds for treating spinal muscular atrophy
12/25/14Anti-bv8 antibodies and uses thereof
08/07/14Pharmaceutical compounds
06/05/14Method for conducting platelet aggregation analysis
02/06/14Dihydroxypyrimidine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
11/28/137-oxo-thiazolopyridine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
11/07/13Devices and methods for automatically reconstituting a drug
11/07/13Drug reconstitution and delivery device
09/26/13Pyrazolopyridine compounds, compositions and methods of use
09/26/13Quinazoline carboxamide azetidines
09/05/13Pharmaceutical compounds
07/04/13Neuropilin as a biomarker for bevacizumab combination therapies
07/04/13Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy
06/13/13Delivery system for diagnostic and therapeutic agents
05/16/13Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancer
05/09/13Expression vector
05/02/13Blood plasma biomarkers for bevacizumab combination therapies for treatment of pancreatic cancer
05/02/13Immunoglobulin aggregate removal
01/24/13Methods and compositions for diagnostic use in cancer patients
12/27/12Method of culturing eukaryotic cells
11/22/12Pharmaceutical formulation for proteins
11/08/12Pharmaceutical compounds
07/05/12Purification of erythropoietin
03/15/12Scoring system for the prediction of cancer recurrence
10/27/11Redox mediators
09/15/11Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use
07/21/11Oligonucleotides for genotyping thymidylate synthase gene
07/14/11Pyrazolopyrimidine pi3k inhibitor compounds and methods of use
06/23/11Antiviral nucleosides
01/27/11Thienopyrimidine derivatives as p13k inhibitors
Patent Packs
11/18/10Heterocyclyl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents
11/04/10Pharmaceutical compounds
09/16/10Reagent devices
05/13/10Method for the production of insulin-like growth factor-1
04/08/10System and robotic storage of microplates
03/18/10Sample carrier
03/18/10Control of ph in formaldehyde-free binder systems
02/11/10Convection barrier
01/21/10Pyrimidine derivatives as pi3k inhibitors
01/14/10Convection barrier
08/20/09Pharmaceutical compounds
08/13/09Crimping device
06/04/09Tricyclic lactam derivatives, their manufacture and use as pharmaceutical agents
04/16/09Method for the purification of antibodies
09/12/13Concentrated polypeptide formulations with reduced viscosity
Patent Packs







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with F Hoffmann la Roche Ag in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for F Hoffmann la Roche Ag with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';